Literature DB >> 7479825

Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.

S N Constantinescu1, E Croze, A Murti, C Wang, L Basu, D Hollander, D Russell-Harde, M Betts, V Garcia-Martinez, J E Mullersman, L M Pfeffer.   

Abstract

The IFNAR chain of the type I interferon (IFN) receptor (IFNIR) undergoes rapid ligand-dependent tyrosine phosphorylation and acts as a species-specific transducer for type I IFN action. Using the vaccinia/T7 expression system to amplify IFNAR expression, we found that human HeLa-S3 cells transiently express high levels of cell surface IFNAR chains (approximately 250,000 chains per cell). Metabolic labeling and immunoblot analysis of transfected HeLa cells show that the IFNAR chain is initially detected as 65-kDa and 98-kDa precursors, and then as the 130-kDa mature protein. Due to variation in N-glycosylation, the apparent molecular mass of the mature IFNAR chain varies from 105 to 135 kDa in different cells. IFNIR structure was characterized in various human cell lines by analyzing 125I-labeled IFN cross-linked complexes recognized by various antibodies against IFNIR subunits and JAK protein-tyrosine kinases. Precipitation of cross-linked material from Daudi cells with anti-IFNAR antibodies showed that IFNAR was present in a 240-kDa complex. Precipitation of cross-linked material from U937 cells with anti-TYK2 sera revealed a 240-kDa complex, which apparently did not contain IFNAR and was not present in IFN-resistant HEC1B cells. The tyrosine phosphorylation and down-regulation of the IFNAR chain were induced by type I IFN in several human cell lines of diverse origins but not in HEC1B cells. However, of type I IFNs, IFN-beta uniquely induced the tyrosine phosphorylation of a 105-kDa protein associated with the IFNAR chain in two lymphoblastoid cell lines (Daudi and U266), demonstrating the specificity of transmembrane signaling for IFN-beta and IFN-alpha through the IFNAR chain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479825      PMCID: PMC40636          DOI: 10.1073/pnas.92.23.10487

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Antibodies to a cell-surface component coded by human chromosome 21 inhibit action of interferon.

Authors:  M Revel; D Bash; F H Ruddle
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

2.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 3.  The interferon receptors.

Authors:  M Rubinstein; P Orchansky
Journal:  CRC Crit Rev Biochem       Date:  1986

4.  Characterization of three monoclonal antibodies that recognize the interferon alpha 2 receptor.

Authors:  O R Colamonici; F D'Alessandro; M O Diaz; S A Gregory; L M Neckers; R Nordan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Characterization of interferon-alpha binding sites on human cell lines.

Authors:  C Vanden Broecke; L M Pfeffer
Journal:  J Interferon Res       Date:  1988-12

6.  Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA.

Authors:  G Uzé; G Lutfalla; I Gresser
Journal:  Cell       Date:  1990-01-26       Impact factor: 41.582

7.  Interaction of interferon with cellular receptors. Internalization and degradation of cell-bound interferon.

Authors:  A A Branca; C R Faltynek; S B D'Alessandro; C Baglioni
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

8.  Cytoskeletal association of human alpha-interferon-receptor complexes in interferon-sensitive and -resistant lymphoblastoid cells.

Authors:  L M Pfeffer; N Stebbing; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21.

Authors:  A Raziuddin; F H Sarkar; R Dutkowski; L Shulman; F H Ruddle; S L Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

10.  Role of interferon alpha/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha/beta receptor complex.

Authors:  S N Constantinescu; E Croze; C Wang; A Murti; L Basu; J E Mullersman; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

View more
  16 in total

1.  Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.

Authors:  R M Arduini; K L Strauch; L A Runkel; M M Carlson; X Hronowski; S F Foley; C N Young; W Cheng; P S Hochman; D P Baker
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  IFNalpha/beta promotes cell survival by activating NF-kappa B.

Authors:  C H Yang; A Murti; S R Pfeffer; L Basu; J G Kim; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  West Nile virus infection induces depletion of IFNAR1 protein levels.

Authors:  Jared D Evans; Rachel A Crown; Ji A Sohn; Christoph Seeger
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

4.  The crystal structure of human interferon beta at 2.2-A resolution.

Authors:  M Karpusas; M Nolte; C B Benton; W Meier; W N Lipscomb; S Goelz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 5.  Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Authors:  Sabelo Lukhele; Giselle M Boukhaled; David G Brooks
Journal:  Semin Immunol       Date:  2019-05-30       Impact factor: 11.130

6.  STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities.

Authors:  C H Yang; A Murti; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

7.  Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy.

Authors:  Birte Kalveram; Olga Lihoradova; Sabarish V Indran; Tetsuro Ikegami
Journal:  J Vis Exp       Date:  2011-11-01       Impact factor: 1.355

8.  Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR.

Authors:  Birte Kalveram; Olga Lihoradova; Sabarish V Indran; Nandadeva Lokugamage; Jennifer A Head; Tetsuro Ikegami
Journal:  Virology       Date:  2012-10-12       Impact factor: 3.616

9.  Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor.

Authors:  Sabyasachi Bhattacharya; Wei-Chun HuangFu; Jianghuai Liu; Sudhakar Veeranki; Darren P Baker; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

10.  The role of TRAF2 binding to the type I interferon receptor in alternative NF kappaB activation and antiviral response.

Authors:  Chuan He Yang; Aruna Murti; Susan R Pfeffer; Meiyun Fan; Ziyun Du; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2008-03-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.